MORGAN GIBBONS: Open Payments
NPI 1083274575 · HICKORY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,990 in 119 payments from 29 companies in 2025. Trend: 2023 $1,505 · 2024 $1,417 · 2025 $1,990
Food & beverage: $1,990
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 19 | $454 |
| ABBVIE INC. | 22 | $254 |
| PFIZER INC. | 10 | $163 |
| Amgen Inc. | 14 | $140 |
| Novo Nordisk Inc | 6 | $102 |
| Lundbeck LLC | 4 | $86 |
| GlaxoSmithKline, LLC. | 4 | $85 |
| Otsuka America Pharmaceutical, Inc. | 4 | $81 |
| Lilly USA, LLC | 5 | $81 |
| Axsome Therapeutics, Inc. | 3 | $56 |
Products named: FARXIGA, REXULTI, UBRELVY, BREZTRI, OTEZLA, VRAYLAR, TRELEGY ELLIPTA, MOUNJARO.
Industry payments across NC — which companies pay providers there.
